STOCKSCREENR
Log In

PRCT

NASDAQ

PROCEPT BioRobotics Corporation

$27.36-0.63(-2.25%)Mkt Cap: $1.54B

Key Stats

Market Cap

$1.54B

P/E Ratio

-15.91

EPS

$-1.72

Dividend Yield

0.00%

52-Week Range

$19.35 — $66.85

Volume

1.46M

Avg Volume

1.61M

Beta

1.02

Valuation

P/E (TTM)

-15.91

Forward P/E

—

PEG Ratio

1.31

P/S (TTM)

5.09

P/B (TTM)

4.23

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.25%

ROA (TTM)

-0.19%

ROIC

—

Gross Margin

0.64%

Operating Margin

-0.34%

Net Margin

—

Debt/Equity

0.14

Current Ratio

6.85

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.18%

EPS Growth (5Y)

-0.22%

Sales Growth (3Y)

+0.88%

Sales Growth (5Y)

+1.27%

EPS Est (This Year)

$-1.14

EPS Est (Next Year)

$-0.62

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$5.14

Analyst Consensus

Price Target Range

$47.00$51.00$62.00
LowMedianHigh

Consensus Target: $53.71(96.3% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

0

Outstanding Shares

55.88M

Float

53.81M

Free Float %

96.29%

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NASDAQ

IPO Date

2021-09-15

Employees

756

CEO

Larry L. Wood

Index Membership

—

Website

https://www.procept-biorobotics.com

PROCEPT BioRobotics Corporation (PRCT) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $1.54B, a P/E ratio of -15.91, PRCT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PRCT against other stocks using dozens of fundamental and technical filters.

Similar Stocks

BIO

Bio-Rad Laboratories, Inc.

$269.48

+3.15%

$7.27B

AVNS

Avanos Medical, Inc.

$13.61

-1.52%

$632.91M

OFIX

Orthofix Medical Inc.

$12.03

+1.35%

$482.94M

AHCO

AdaptHealth Corp.

$10.45

+0.29%

$1.42B

LAB

Standard BioTools Inc.

$0.98

+3.01%

$378.30M

IRMD

IRadimed Corporation

$102.80

+1.09%

$1.31B

Frequently Asked Questions

What is PROCEPT BioRobotics Corporation's P/E ratio?

PROCEPT BioRobotics Corporation (PRCT) has a trailing twelve-month (TTM) P/E ratio of -15.91. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does PROCEPT BioRobotics Corporation pay a dividend?

No, PROCEPT BioRobotics Corporation (PRCT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is PROCEPT BioRobotics Corporation's market cap?

PROCEPT BioRobotics Corporation (PRCT) has a market capitalization of $1.54 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.